Investigation of Serum Antimullerian Hormone Levels in Adolescent Epilepsy Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- serum anti-mullerian hormone levels
研究概览
简要总结
The production of AMH starts in granulosa cells before birth and the levels within the serum decreases towards the menapouse. The levels of AMH do not change throughout the menstruation cycle hovewer, it can be affected in cases related to body mass index (BMI), polycyctic ovarian syndrome (PCOS). The lower levels of AMH had been documented after ovarian surgery, radiotheraphy and chemotheraphy. AMH is a member of Transforming Growth Faktor β (TGF- β ) and it has receptors in brain structures including hyppocammpus. It is highly active neurophysiologically and it has a protective effect against N-methyl-D -aspartate related neuronal injury that is demonstrated both in vivo and in vitro studies. As a result, being a neuroactive hormone; AMH may have an effect on seizures within epileptic patients or serum AMH levels may be effected in epileptic patients when compared with healthy ones.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 18 Years(Child, Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy and epileptic volunteer females
- •Ages between 12-18
- •After menarche
排除标准
- •ovarian surgery,
- •history of radiotherapy
- •history of chemotherapy,
- •before menarche
结局指标
主要结局
serum anti-mullerian hormone levels
时间窗: baseline, at the time of examination
The comparison of serum levels of anti-mullerian hormone between epileptic and healthy groups
次要结局
未报告次要终点
研究者
Ali Cenk
Medical Doctor, Associate Professor
Near East University, Turkey
